Home > Result Summaries: Compounds > GSK2239633 Result Summaries: GSK2239633 GSKStudy ID Phase Title Summary (Download) 114041 phase 1 A Microdose Study to Describe the Intravenous Pharmacokinetics of [14C]-GSK2239633 in Healthy Male Subjects (1 citation(s)) 114660 phase 1 A randomised, double-blind, placebo-controlled, cross-over study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending oral doses of GSK2239633 in healthy male subjects. (1 citation(s))
